pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
- 1 November 1991
- journal article
- Published by Wiley in Histopathology
- Vol. 19 (5), 403-410
- https://doi.org/10.1111/j.1365-2559.1991.tb00229.x
Abstract
Morphological assessment of the degree of differentiation has been shown in numerous studies to provide useful prognostic information in breast cancer, but until recently histological grading has not been accepted as a routine procedur mainly because of perceived problems with reproducibility and consistency. In the Nottingham/Tenovus Primary Breast Cancer Study the most commonly used method, described by Bloom & Richardson, has been modified in order to make the criteria more objective. The revised technique involves semiquantitative evaluation of three morphological features–the percentage of tubule formation, the degree of nuclear pleomorphism and an accurate mitotic count using a defined field area. A numerical scoring system is used and the overall grade is derived from a summation of individual scores for the three variables; three grades of differentiation are used. Since 1973, over 2200 patients with primary operable breast cancer have been entered into a study of multiple prognostic factors. Histological grade, assessed in 1831 patients, shows a very strong correlation with prognosis; patients with grade I tumours have a significantly better survival than those with grade II and III tumours (P<0.0001). These results demonstrate that this method for histological grading provides important prognostic information and, if the grading protocol is followed consistently, reproducible results can be obtained. Histological grade forms part of the multifactorial Nottingham prognostic index, together with tumour size and lymph node stage, which is used to stratify individual patients for appropriate therapy.Keywords
This publication has 39 references indexed in Scilit:
- Expression of epidermal growth factor receptor in breast carcinoma.Journal of Clinical Pathology, 1990
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988
- Cellular and molecular aspects of neoplastic progression in the mammary glandEuropean Journal of Cancer and Clinical Oncology, 1988
- Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variablesThe Journal of Pathology, 1987
- THE ASSESSMENT OF HISTOLOGICAL DIFFERENTIATION IN BREAST CANCER*Anz Journal of Surgery, 1984
- Analysis of reproducibility of subjective grading systems for breast carcinoma.Journal of Clinical Pathology, 1979
- Prognosis in breast cancer utilizing histologic characteristics of the primary tumorCancer, 1975
- Prognosis in breast cancer utilizing histologic characteristics of the primary tumorCancer, 1975
- Ploidy and histological types of mammary carcinomasEuropean Journal of Cancer (1965), 1968
- Ueber asymmetrische Zelltheilung in Epithelkrebsen und deren biologische BedeutungVirchows Archiv, 1890